The results clarified that, compared to PTX-sensitive patients, the expression levels of RBM15 and TNFSF9 were abnormally high in the tumor tissues of PTX-resistant patients, and there was a relatively significant positive correlation between the two. Here, RBM15 is linked to neoplasm.